Evaluation of promoter hypermethylation of tumor suppressor gene BRCA1 in epithelial ovarian cancer.

Das, Jhuma; Chandra, Lal; Gandhi, Gauri; Amle, Dnyanesh B; Patnayak, Rachana L; Khurana, Nita; Saxena, Alpana

Das, Jhuma; Chandra, Lal; Gandhi, Gauri; Amle, Dnyanesh B; Patnayak, Rachana L; Khurana, Nita; Saxena, Alpana.

Afiliação

Das J; Department of Biochemistry, Maulana Azad Medical College, New Delhi, India.
Chandra L; Department of Biochemistry, Maulana Azad Medical College, New Delhi, India.
Gandhi G; Department of Obstetrics and Gynaecology, Maulana Azad Medical College, New Delhi, India.
Amle DB; Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Patnayak RL; Department of Biochemistry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Khurana N; Department of Pathology, Maulana Azad Medical College, New Delhi, India.
Saxena A; Department of Biochemistry, Maulana Azad Medical College, New Delhi, India.

J Cancer Res Ther ; 18(6): 1578-1582, 2022.

Article em En | MEDLINE | ID: mdl-36412414

Assuntos

Neoplasias Ovarianas; Feminino; Humanos; Proteína BRCA1/genética; Carcinoma Epitelial do Ovário/genética; Estudos de Casos e Controles; Genes BRCA1; Neoplasias Ovarianas/genética; Regiões Promotoras Genéticas/genética; Metilação de DNA

Palavras-chave

B12; BRCA1; CA125; epithelial ovarian cancer; folic acid; promoter hypermethylation; tumor suppressor gene

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Observational_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google